Legacy Advisors’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$143M Sell
3,431,467
-98,267
-3% -$3.94M 13.36% 1
2026
Q1
$128M Buy
3,529,734
+35,950
+1% +$1.38M 15.08% 1
2025
Q4
$134M Buy
3,493,784
+347,969
+11% +$13.1M 14.43% 1
2025
Q3
$114M Buy
3,145,815
+3,056,632
+3,427% +$107M 14.09% 1
2025
Q2
$2.6M Buy
+89,183
New +$2.83M 41.13% 1

Other funds holding QLTY

Legacy Advisors's QLTY Position: Q2 2026 in Review

Legacy Advisors reduced its GMO US Quality ETF (QLTY) stake by 2.8% in Q2 2026, selling an estimated $3.94M and leaving 3,431,467 shares worth $143M. The position accounts for 13.36% of the portfolio, ranked #1.

Legacy Advisors first reported a position in QLTY in Q2 2025 and has held it in 5 quarters since. 48 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Legacy Advisors held 3,431,467 shares of GMO US Quality ETF worth $143M as of Q2 2026.
  • Legacy Advisors sold 98,267 GMO US Quality ETF shares in Q2 2026, an estimated $3.94M.
  • GMO US Quality ETF made up 13.36% of Legacy Advisors's portfolio in Q2 2026, its #1 holding.
  • Legacy Advisors first reported a position in GMO US Quality ETF in Q2 2025 and has held it in 5 quarters since.
  • 48 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Legacy Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.